Abstract
Background and purpose
Materials and methods
Results
Conclusions
Keywords
1. Introduction
European Commission, Directorate-General for Energy, General guidelines on risk management in external beam radiotherapy, Publications Office, 2015, https://data.europa.eu/doi/10.2833/667305 [accessed 20 July 2022].
European Commission, Directorate-General for Energy, General guidelines on risk management in external beam radiotherapy, Publications Office, 2015, https://data.europa.eu/doi/10.2833/667305 [accessed 20 July 2022].
Malicki J, Bly R, Bulot M, Godet JL, Jahnen A, Krengli M, et al. Patient safety in external beam radiotherapy, results of the ACCIRAD project: Current status of proactive risk assessment, reactive analysis of events, and reporting and learning systems in Europe. Radiother Oncol 2017;123:29-36. https://doi: 10.1016/j.radonc.2017.02.016.
2. Material and methods
2.1 Treatment planning process

2.2 Error classification
3. Results
Description | Frequency | Barrier in TPS | |
---|---|---|---|
G-Errors | |||
Wrong gantry angle at setup field | Two setup fields are defined at 0° and 90°/270°. If a gantry angle is not correct, the setup field will be modified prior acquisition. | 19 | (T) |
Wrong dose/number of fractions | A wrong dose or number of fractions compared to prescription was entered in the TPS. This can result in over or under dose to the target volume and over dose to healthy tissues. | 5 | (T) |
Wrong gantry angle | Wrong gantry angle means the gantry angle is erroneously deviating from a predefined planning technique like a box; e.g. 95° gantry angle instead of 90°. | 5 | (T) |
MLC not conformal to planning target volume (PTV) | The MLC was not properly adjusted in regard to the PTV. | 2 | |
Isocenter not defined or at false position | If the isocenter is not or falsely defined the TPS uses the Dicom center as isocenter. This means after patient setup using simulation markers, a wrong couch shift can be applied for the setup images. A wrong delivery of a treatment field will most likely not occur as the correct field position is checked by a setup field. | 2 | |
S-Errors | |||
Wrong field label | Treatment fields are labelled according to the gantry rotation. Even if this is incorrect the correct treatment will be applied. | 24 | |
Wrong machine | The treatment plan is calculated for a wrong treatment machine. This can mean a swap between the two Artiste linacs (which are identical in regard of dosimetry) or a swap between Artiste and TrueBeamSTx. Incorrect treatment is not possible. This issue can result in a new treatment planning or affect the patient logistic. | 7 | |
Setup field with MLC | In the considered clinic open setup fields without MLCs are created; in other clinics the MLC might be included in the setup field. To include an MLC in the setup field is a deviation from internal clinical rules and no g-error as the acquisition of the setup field with MLC would not be repeated with a setup field without MLC. | 7 | (T) |
Isocenter position not rounded | Typically, in the considered workflow isocenter positions are rounded to half of a centimeter. To omit this is a violation of internal clinical rules but cannot result in wrong treatment. | 4 | |
Primary reference point for IMRT/VMAT with location | In the considered treatment plans, normally a primary reference point with location and plan normalization (100 % dose) is used. For VMAT or IMRT and some 3D technique, the normalization is done differently (e.g. 100 % at target mean). In these cases, a location of the primary reference point might result in an incorrect dose reporting. | 4 | |
No DRR for setup field created | DRRs (digital reconstructed radiographs) are created in the TPS and are linked to the setup field. If a DRR is not created this will be done at the console of the linac. | 3 | |
Fields with zero dose rate | If a treatment field is defined without a dose-rate definition, a plan approval is not possible. | 3 | T |
MLC exceeds physical constraints | Leaf positions and movements are restricted by physical constraints as maximum leaf overtravel and leaf span. In some cases, e.g. after manual adjustment of leaf positions, it can occur that these are not fully met after dose calculation. When such plans are approved an error message appears. A verification of MLC positions in the TPS is needed followed by new dose calculation. | 3 | T |
Jaws not collimating the MLC field | For MLC fields the collimation by the jaws must match the MLC aperture to minimize dose leakage within the range of the leaf width. This is not the case in clinics where back-up jaws are set to the maximum aperture of all field segments. | 2 | |
Old plan version printed | Treatment plans are still printed in the considered clinic for archiving and handout at the linac. If a wrong version was printed this cannot result in a wrong treatment, because the approved correct digital treatment plan is transferred to the linac and differences with the printed plan will attract attention. | 2 | |
Bad printout quality | By bad printout quality of a treatment plan, like improper zoom settings in isodose representation, no wrong treatment can emerge as the correct plan parameters are used in ARIA. | 2 | |
Not enough dose from field at primary reference point | The primary reference point receives a dose contribution from every field in the treatment plan. If the reference point is located far away from one or more treatment fields their dose contribution will be too low to be considered. A plan approval is not possible. In such cases either the location of the primary reference point has to be adjusted or the reference point is changed to a reference point without location. | 2 | T |
Primary reference point undefined | Without a primary reference point plan approval is not possible. | 2 | T |
Wrong energy for setup field | If a wrong energy of a setup field is set, the treatment plan can be approved, but the setup field cannot be acquired. | 2 | T |
Number of plans | Percentage of plans | Number of errors | Percentage of plans with errors | |
---|---|---|---|---|
Treatment machine | ||||
2x Artiste | 689 | 65 % | 67 | 10 % |
1x TrueBeamSTx | 367 | 35 % | 43 | 12 % |
Treatment technique | ||||
3D | 767 | 73 % | 84 | 11 % |
IMRT | 18 | 2 % | 1 | 6 % |
VMAT | 220 | 21 % | 20 | 9 % |
AMAT | 51 | 5 % | 5 | 10 % |
Anatomical site | ||||
Brain | 116 | 11 % | 8 | 7 % |
H&N | 100 | 10 % | 12 | 12 % |
Breast | 210 | 20 % | 29 | 14 % |
Extremities | 43 | 4 % | 3 | 7 % |
Chest | 274 | 26 % | 22 | 8 % |
Pelvis (no prostate) | 195 | 19 % | 28 | 14 % |
Prostate | 118 | 11 % | 8 | 7 % |

4. Discussion
Empfehlungen von BfS, DEGRO, DGMP und DGN zur Risikoanalyse bei therapeutischen Strahlenanwendungen nach Artikel 63 Buchstabe b der EU-Direktive 2013/59/Euratom, Dec. 2015, https://www.bfs.de/SharedDocs/Downloads/BfS/DE/fachinfo/ion/empfehlungen-risikoanalyse.html [accessed July 20 2022].
Declaration of Competing Interest
Appendix A. Supplementary data
- Supplementary Data 1
References
European Commission, Directorate-General for Energy, General guidelines on risk management in external beam radiotherapy, Publications Office, 2015, https://data.europa.eu/doi/10.2833/667305 [accessed 20 July 2022].
- The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management.Med Phys. 2016; 43: 4209-4262https://doi.org/10.1118/1.4947547
Ford E, Conroy L, Dong L, de Los Santos LF, Greener A, Gwe-Ya Kim G, et al. Strategies for effective physics plan and chart review in radiation therapy: Report of AAPM Task Group 275. Med Phys 2020;47:236-72. https://doi: 10.1002/mp.14030.
- Quality control quantification (QCQ): a tool to measure the value of quality control checks in radiation oncology.Int J Radiat Oncol Biol Phys. 2012; 84: 263-269https://doi.org/10.1016/j.ijrobp.2012.04.036
Malicki J, Bly R, Bulot M, Godet JL, Jahnen A, Krengli M, et al. Patient safety in external beam radiotherapy, results of the ACCIRAD project: Current status of proactive risk assessment, reactive analysis of events, and reporting and learning systems in Europe. Radiother Oncol 2017;123:29-36. https://doi: 10.1016/j.radonc.2017.02.016.
- Consensus recommendations for incident learning database structures in radiation oncology.Med Phys. 2012; 39: 7272-7290https://doi.org/10.1118/1.4764914
- Improving treatment plan evaluation with automation.J Appl Clin Med Phys. 2016; 17: 16-31https://doi.org/10.1120/jacmp.v17i6.6322
ASN-SFRO Experimental Scale for the Rating of Radiation Protection Events Affecting Patients Undergoing a Radiotherapy Procedure. Paris, France: Autorité de sûreté nucléaire, société française de radiothérapie oncologique; 2007.
- Radiation therapy plan checks in a paperless clinic.J Appl Clin Med Phys. 2009; 10: 43-62https://doi.org/10.1120/jacmp.v10i1.2905
- Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance. Phys Imaging.Radiat Oncol. 2020; 16: 144-148https://doi.org/10.1016/j.radonc.2020.09.008
Empfehlungen von BfS, DEGRO, DGMP und DGN zur Risikoanalyse bei therapeutischen Strahlenanwendungen nach Artikel 63 Buchstabe b der EU-Direktive 2013/59/Euratom, Dec. 2015, https://www.bfs.de/SharedDocs/Downloads/BfS/DE/fachinfo/ion/empfehlungen-risikoanalyse.html [accessed July 20 2022].
- Using failure mode and effects analysis to evaluate risk in the clinical adoption of automated contouring and treatment planning tools.Pract Radiat Oncol. 2022; 12: 344-353https://doi.org/10.1016/j.prro.2022.01.003
- Utilizing simulated errors in radiotherapy plans to quantify the effectiveness of the physics plan review.Med Phys. 2018; 45: 5359-5365https://doi.org/10.1002/mp.13242
- Characterization of a Bayesian network-based radiotherapy plan verification model.Med Phys. 2019; 46: 2006-2014https://doi.org/10.1002/mp.13515
- Early detection of potential errors during patient treatment planning.J Appl Clin Med Phys. 2018; 19: 724-732https://doi.org/10.1002/acm2.12388
- Evaluation of a prospective radiation oncology departmental team review process using standardized simulation directives.Radiother Oncol. 2022; 170: 102-110https://doi.org/10.1016/j.radonc.2021.12.028
- Chasing zero harm in radiation oncology: using pre-treatment peer review.Front Oncol. 2019; 9: 1-12https://doi.org/10.3389/fonc.2019.00302
Article info
Publication history
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy